Concepedia

N. Wake

NW

Statistics

Publications

8

Citations

645

H-Index

8

Active since

1995

Affiliations

University of Birmingham(Current)

Birmingham Women's Hospital

University of Wolverhampton

Manchester Academic Health Science Centre

Cancer Research UK Manchester Institute

N. Wake is an author at University of Birmingham specializing in genetics, cancer genetics, and molecular oncology.

Publications per year

1995–2016

8

Publications

8

Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility

Dewi Astuti, Mark R. Morris, Wendy N. Cooper et al. · Nature Genetics · 2012 · 252 citations

, , +16

Germline Mutations in the<i>CDKN2B</i>Tumor Suppressor Gene Predispose to Renal Cell Carcinoma

Mariam Jafri, N. Wake, David B. Ascher et al. · Cancer Discovery · 2015 · 92 citations

, , +17

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis

Jane Birtwistle, Rachel E. Hayden, Farhat L. Khanim et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2009 · 81 citations

, , +16

Cytologic evidence for preferential inactivation of the paternally derived X chromosome in XX mouse blastocysts

Nobuo Takagi, N. Wake, M. Sasaki · Cytogenetics and Cell Genetics · 2008 · 74 citations

, , +12

Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma

Christopher J. Ricketts, Mark R. Morris, Dean Gentle et al. · Epigenetics · 2012 · 57 citations · Full text

, , +17

1–5 of 8